Abstract
We developed the LigAmp assay for sensitive detection and accurate quantification of viruses and cells with single-base mutations. In LigAmp, two oligonucleotides are hybridized adjacently to a DNA template. One oligonucleotide matches the target sequence and contains a probe sequence. If the target sequence is present, the oligonucleotides are ligated together and detected using real-time PCR. LigAmp detected KRAS2 mutant DNA at 0.01% in mixtures of different cell lines. KRAS2 mutations were also detected in pancreatic duct juice from patients with pancreatic cancer. LigAmp detected the K103N HIV-1 drug resistance mutation at 0.01% in plasmid mixtures and at ∼0.1% in DNA amplified from plasma HIV-1. Detection in both systems is linear over a broad dynamic range. Preliminary evidence indicates that reactions can be multiplexed. This assay may find applications in the diagnosis of genetic disorders and the management of patients with cancer and infectious diseases.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on SpringerLink
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Vary, C.P. et al. Allele-specific hybridization of lipoprotein lipase and factor-V Leiden missense mutations with direct label alkaline phosphatase-conjugated oligonucleotide probes. Genet. Anal. 13, 59–65 (1996).
Chen, J. & Viola, M.V. A method to detect ras point mutations in small subpopulations of cells. Anal. Biochem. 195, 51–56 (1991).
Redston, M.S., Papadopoulos, N., Caldas, C., Kinzler, K.W. & Kern, S.E. Common occurrence of APC and K-ras gene mutations in the spectrum of colitis-associated neoplasias. Gastroenterology 108, 383–392 (1995).
Rothschild, C.B., Brewer, C.S., Loggie, B., Beard, G.A. & Triscott, M.X. Detection of colorectal cancer K-ras mutations using a simplified oligonucleotide ligation assay. J. Immunol. Methods 206, 11–19 (1997).
Clayton, S.J. et al. K-ras point mutation detection in lung cancer: comparison of two approaches to somatic mutation detection using ARMS allele-specific amplification. Clin. Chem. 46, 1929–1938 (2000).
Takeda, S., Ichii, S. & Nakamura, Y. Detection of K-ras mutation in sputum by mutant-allele-specific amplification (MASA). Hum. Mutat. 2, 112–117 (1993).
Germer, S., Holland, M.J. & Higuchi, R. High-throughput SNP allele-frequency determination in pooled DNA samples by kinetic PCR. Genome Res. 10, 258–266 (2000).
Kwok, S. et al. Effects of primer-template mismatches on the polymerase chain reaction: human immunodeficiency virus type 1 model studies. Nucleic Acids Res. 18, 999–1005 (1990).
McKinzie, P.B. & Parsons, B.L. Detection of rare K-ras codon 12 mutations using allele-specific competitive blocker PCR. Mutat. Res. 517, 209–220 (2002).
Lichtenstein, A.V., Serdjuk, O.I., Sukhova, T.I., Melkonyan, H.S. & Umansky, S.R. Selective 'stencil'-aided pre-PCR cleavage of wild-type sequences as a novel approach to detection of mutant K-RAS. Nucleic Acids Res. 29, E90-0 (2001).
Schimanski, C.C., Linnemann, U. & Berger, M.R. Sensitive detection of K-ras mutations augments diagnosis of colorectal cancer metastases in the liver. Cancer Res. 59, 5169–5175 (1999).
Kaur, M. et al. Ligation of a primer at a mutation: a method to detect low-level mutations in DNA. Mutagenesis 17, 365–374 (2002).
Oliver, D.H., Thompson, R.E., Griffin, C.A. & Eshleman, J.R. Use of single-nucleotide polymorphisms (SNP) and real-time polymerase chain reaction for bone marrow engraftment analysis. J. Mol. Diagn. 2, 202–208 (2000).
Srivastava, S. & Rossi, S.C. Early detection research program at the NCI. Int. J. Cancer 69, 35–37 (1996).
Sidransky, D. et al. Identification of ras oncogene mutations in the stool of patients with curable colorectal tumors. Science 256, 102–105 (1992).
Traverso, G. et al. Detection of APC mutations in fecal DNA from patients with colorectal tumors. N. Engl. J. Med. 346, 311–320 (2002).
Wilentz, R.E. et al. K-ras mutations in the duodenal fluid of patients with pancreatic carcinoma. Cancer 82, 96–103 (1998).
Mulcahy, H. & Farthing, M.J. Diagnosis of pancreatico-biliary malignancy: detection of gene mutations in plasma and stool. Ann. Oncol. 10, 114–117 (1999).
Hruban, R.H., Wilentz, R.E. & Kern, S.E. Genetic progression in the pancreatic ducts. Am. J. Pathol. 156, 1821–1825 (2000).
Caldas, C. et al. Detection of K-ras mutations in the stool of patients with pancreatic adenocarcinoma and pancreatic ductal hyperplasia. Cancer Res. 54, 3568–3573 (1994).
Watanabe, H. et al. Quantitative determination of K-ras mutations in pancreatic juice for diagnosis of pancreatic cancer using hybridization protection assay. Pancreas 17, 341–347 (1998).
Tada, M. et al. Quantitative analysis of ras gene mutation in pancreatic juice for diagnosis of pancreatic adenocarcinoma. Dig. Dis. Sci. 43, 15–20 (1998).
Laghi, L. et al. Common occurrence of multiple K-RAS mutations in pancreatic cancers with associated precursor lesions and in biliary cancers. Oncogene 21, 4301–4306 (2002).
Mitchell, C.E., Belinsky, S.A. & Lechner, J.F. Detection and quantitation of mutant K-ras codon 12 restriction fragments by capillary electrophoresis. Anal. Biochem. 224, 148–153 (1995).
Prieto-Alamo, M.J. & Laval, F. Deficient DNA-ligase activity in the metabolic disease tyrosinemia type I. Proc. Natl. Acad. Sci. USA 95, 12614–12618 (1998).
Ciarrocchi, G., MacPhee, D.G., Deady, L.W. & Tilley, L. Specific inhibition of the eubacterial DNA ligase by arylamino compounds. Antimicrob. Agents Chemother. 43, 2766–2772 (1999).
Barringer, K.J., Orgel, L., Wahl, G. & Gingeras, T.R. Blunt-end and single-strand ligations by Escherichia coli ligase: influence on an in vitro amplification scheme. Gene 89, 117–122 (1990).
Schouten, J.P. et al. Relative quantification of 40 nucleic acid sequences by multiplex ligation-dependent probe amplification. Nucleic Acids Res. 30, e57 (2002).
Havlir, D.V., Eastman, S., Gamst, A. & Richman, D.D. Nevirapine-resistant human immunodeficiency virus: kinetics of replication and estimated prevalence in untreated patients. J. Virol. 70, 7894–7899 (1996).
Hirsch, M.S. et al. Antiretroviral drug resistance testing in adults with HIV infection: implications for clinical management. International AIDS Society—USA Panel. JAMA 279, 1984–1991 (1998).
Chiu, R.W. et al. Prenatal exclusion of β-thalassaemia major by examination of maternal plasma. Lancet 360, 998–1000 (2002).
Yukobowich, E. et al. Risk of fetal loss in twin pregnancies undergoing second-trimester amniocentesis(1). Obstet. Gynecol. 98, 231–234 (2001).
Jackson, L.G. et al. A randomized comparison of transcervical and transabdominal chorionic-villus sampling. The U.S. National Institute of Child Health and Human Development Chorionic-Villus Sampling and Amniocentesis Study Group. N. Engl. J. Med. 327, 594–598 (1992).
Fukushima, N. et al. Diagnosing pancreatic cancer using methylation-specific PCR analysis of pancreatic juice. Cancer Biol. Ther. 2, 78–83 (2003).
Eshleman, S.H., Jones, D., Flys, T., Petrauskene, O. & Jackson, J.B. Analysis of HIV-1 variants by cloning DNA generated with the ViroSeq HIV-1 Genotyping System. Biotechniques 35, 614–618, 620, 622 (2003).
Acknowledgements
We thank A. Maitra, B. Wendelburg (Cepheid), J.B. Jackson, K. Kinzler, B. Vogelstein, K. Murphy, M. Slater, J. Strain (Applied Biosystems) and K. Brune for helpful discussions; J. Mellors (University of Pittsburgh) for providing plasmids containing HIV-1 molecular clones with and without the K103N mutation; and S. Hudelson for excellent technical assistance. This work was supported by grant R01 CA81439 from the National Cancer Institute, and the Maryland Cigarette Restitution Fund (to J.R.E.), by the HIV Prevention Trials Network sponsored by the National Institute for Allergies and Infectious Diseases (NIAID), National Institutes of Child Health and Human Development, National Institute on Drug Abuse, National Institute of Mental Health and Office of AIDS Research of the National Institutes of Health (NIH), Department of Health and Human Services (U01-AI-46745 and U01-AI-48054) and the Adult AIDS Clinical Trials Groups (NIH, Division of AIDS, NIAID, U01-AI-38858) and R01-HD042965-01 (to S.H.E.), by National Cancer Institute SPORE grant P50-CA-62924, and by a Fellowship from the Canadian Institute of Health Research (to C.S.).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
Johns Hopkins University has filed a patent application with the US Patent and Trademark Office.
Supplementary information
Supplementary Table 1
Oligonucleotides and probes (PDF 21 kb)
Rights and permissions
About this article
Cite this article
Shi, C., Eshleman, S., Jones, D. et al. LigAmp for sensitive detection of single-nucleotide differences. Nat Methods 1, 141–147 (2004). https://doi.org/10.1038/nmeth713
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/nmeth713
This article is cited by
-
Sensitive detection of low-abundance in-frame deletions in EGFR exon 19 using novel wild-type blockers in real-time PCR
Scientific Reports (2019)
-
Validation Strategy for Ultrasensitive Mutation Detection
Molecular Diagnosis & Therapy (2018)
-
A Simple Microfluidic Assay for the Detection of Ligation Product
Molecular Diagnosis & Therapy (2015)
-
High-sensitivity PCR method for detecting BRAF V600Emutations in metastatic colorectal cancer using LNA/DNA chimeras to block wild-type alleles
Analytical and Bioanalytical Chemistry (2014)
-
Performance of LigAmp Assay for Sensitive Detection of Drug-Resistant Hepatitis B Virus Minor Variants in Comparison with Standard Nucleotide Sequencing
Molecular Diagnosis & Therapy (2014)